Search hospitals > Massachusetts > Boston

Tufts Medical Center

Claim this profile
Boston, Massachusetts 02111
Global Leader in High Blood Pressure
Global Leader in Pulmonary Hypertension
Conducts research for Heart Failure
Conducts research for Breast Cancer
Conducts research for Lymphoma
863 reported clinical trials
61 medical researchers
Photo of Tufts Medical Center in BostonPhoto of Tufts Medical Center in BostonPhoto of Tufts Medical Center in Boston

Summary

Tufts Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of High Blood Pressure, Pulmonary Hypertension, Heart Failure, Breast Cancer, Lymphoma and other specialties. Tufts Medical Center is involved with conducting 863 clinical trials across 966 conditions. There are 61 research doctors associated with this hospital, such as Jason Law, Katina M. Robison, Nicholas S Hill, MD, and Andreas K. Klein.

Area of expertise

1High Blood Pressure
Global Leader
Tufts Medical Center has run 63 trials for High Blood Pressure. Some of their research focus areas include:
6MWD
CTD-ILD
2Pulmonary Hypertension
Global Leader
Tufts Medical Center has run 57 trials for Pulmonary Hypertension. Some of their research focus areas include:
6MWD
CTD-ILD

Top PIs

Clinical Trials running at Tufts Medical Center

Breast Cancer
Multiple Myeloma
Cancer
Lung Cancer
Testicular cancer
Amyloidosis
Multiple Sclerosis
Parotid Gland Cancer
Squamous Cell Carcinoma
Relapse
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Tufts Medical Center?
Where is Tufts Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Tufts Medical Center accept?
What awards or recognition has Tufts Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security